Tags
- A
- Acro
- Across
- Adjuvant
- Advancement
- Agent
- Alive
- An
- Antibody
- Antibody-drug conjugate
- Approved
- Author
- Authors
- BIND
- Biomarker
- Biomarkers
- Breast
- Breast cancer
- Cancer
- Cancer center
- Cancer centers
- Cancer Institute
- Cancer recurrence
- Centers
- Chance
- Chemotherapy
- Chief
- Clinical
- Clinical Oncology
- Clinical trial
- Conjugate
- Conjunction
- Dana–Farber Cancer Institute
- Detriment
- Division
- Drug
- Effect
- Establishment
- Evidence
- Factor
- Faculty
- Five
- Four
- Fund
- Genentech
- Genes
- Gloria Spivak
- Greater
- Hair
- Hair loss
- HER2/neu
- High Score
- High scores
- Impact
- Interval
- Invasive
- Investigator
- Italy
- Journal
- Journal of Clinical Oncology
- Known
- Komen
- Lead author
- Less
- Link
- Links
- Long term
- Loss
- Lymph
- Lymph node
- Lymph node involvement
- Making It
- M.D.
- Medicine
- Mertansine
- Metástasis
- MPH
- Nause
- Neuropathy
- New
- No
- Node
- Oncology
- One Year
- Outstanding
- Paolo Tarantino
- Participation
- Patient
- Patient-reported outcome
- Patient-reported outcomes
- Perioperative mortality
- Phase
- Phase II
- Phases of clinical research
- Population
- Positive
- Powerful
- Prevention
- Productivity
- Protein
- Proven
- Publishing
- Quality
- Quality of life
- Randomness
- Recurrence
- Recurring
- Reduce
- Remains
- Research
- Researcher
- Result
- Risk
- Risk score
- Score
- Scores
- Select
- Shower
- Side Effects
- Spivak
- Suggest
- Surgery
- Susan G. Komen for the Cure
- Tarantino
- Teacher
- Term
- Tested
- The journal
- The Side Effects
- The trial
- Threshold
- Tissue
- Today
- Toxicity
- Trastuzumab
- Trastuzumab emtansine
- Trial
- Tumor
- University
- University of Milan
- Weigh
- Workforce productivity